Homo sapiens synuclein, alpha (non A4 component of amyloid precursor) (SNCA), transcript variant 1
Synonyms:
NACP; PARK1; PARK4; PD1
Immunogen
The antiserum was produced against synthesized non-phosphopeptide derived from human a-Synuclein around the phosphorylation site of tyrosine 133 (E-G-Y-Q-D).
Buffer
Phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.
Clone Name
Isotype
IgG
Species Reactivity
Human, Mouse, Rat
Concentration
1mg/ml
Purification
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen. (Protein A or G Sepharose)
Guaranteed Application *
WB
Suggested Dilutions
WB: 1:500~1:3000, ELISA: 1:20000
Background
.-Synuclein (Ab-133) antibody detects endogenous levels of total .-Synuclein protein.
Related Pathway
EGFR1 Signaling Pathway
* Shipping is in business days
* OriGene provides validated application data and protocol, with money back guarantee.
Western blot analysis of extracts from 293 cells, treated with Etoposide 25µM 60', using Synuclein-alpha (Ab-133) Antibody.The lane on the right is treated with the synthesized peptide.
Researchers who bought this antibody have also purchased:
